Background: Atrial fibrillation (AF) is the most common coronary artery bypass graft (CABG) post-op arrhythmia. This complication can increase the patient’s chances for a longer hospital stay, stroke, or death; resulting in additional healthcare costs. Prescribing statins (3-hydroxy-3-methylglutaryl COA reductase inhibitors) to reduce the risk of postoperative AF (POAF) is well studied, as they provide anti-inflammatory and antioxidant benefits within hours of initiation. However, whether the statin type and/or dose are the origin for these benefits remains unknown; as research is conflicted.
Methods: This 10 year retrospective observational study at a single institution, included all patients who underwent an isolated CABG; between January
Methods: This 10 year retrospective observational study at a single institution, included all patients who underwent an isolated CABG; between January